Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Blog | Veristat Insightful Perspectives

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Posts about

Clinical Trial Regulations

Monthly FDA Guidance and Regulatory News Review - September 2026

This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral...

Monthly FDA Guidance and Regulatory News Review - August 2026

This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal...

Monthly FDA Guidance and Regulatory News Review - July 2026

This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses...

Monthly FDA Guidance and Regulatory News Review - June 2026

This June 2026 regulatory update focuses on advancing innovative drug development through updated...

Monthly FDA Guidance and Regulatory News Review - May 2026

This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and...

Monthly FDA Guidance and Regulatory News Review - April 2026

 This April 2026 regulatory update highlights new policies on biomarker validation, expanded access...

Monthly FDA Guidance and Regulatory News Review - March 2026

March 2026 regulatory updates underscore newly published final and draft guidances focused on...

Monthly FDA Guidance and Regulatory News Review - February 2026

In February 2026, FDA activity included new draft guidances, regulatory initiatives (e.g., PreCheck...

Monthly FDA Guidance and Regulatory News Review - January 2026

January 2026 regulatory updates underscored evolving AI-focused policies, ongoing scrutiny of...

Monthly FDA Guidance and Regulatory News Review - December 2025

December 2025 capped the year with a robust slate of FDA activity, including multiple final and...